 Background CPC634 is docetaxel entrapped in core cross linked polymeric micelles . In preclinical studies CPC634 demonstrated enhanced pharmacokinetics and improved therapeutic index . This phase I dose escalation study is the first in human study with CPC634 .

@highlight CPC634 consists of docetaxel covalently entrapped in a stabilized 65nm sized core cross linked polymeric micelles CCL PMs 
@highlight The RP2D of CPC634 is 60mg m
@highlight Q3W with dexamethasone premedication
@highlight The most important DLT was cumulative skin toxicity
@highlight The pharmacokinetic profile of CPC634 is dose proportional with prolonged systemic exposure
